Tag: des

CRT 2020: Biotronik reports three-year results for Orsiro DES from BIOFLOW-V...

Biotronik has announced three-year data from the BIOFLOW-V trial, which were presented at the Cardiac Resynchronisation Therapy meeting (CRT 2020; 23–25 February, Washington DC,...
Orsiro Mission DES

Orsiro Mission gets CE mark

Biotronik has received CE mark certification for the Orsiro Mission drug-eluting stent (DES) system. According to a company statement, the next generation of the...

Customising therapy in femoropopliteal revascularisation

 Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based therapies have become a mainstay in femoropopliteal revascularisation and how interventionalists...

Patient recruitment reaches half-way point for global DAPT study

December marked a significant milestone for a major study into the use of short duration dual anti-platelet therapy (DAPT) in high bleeding risk patients...
paclitaxel

Meta-analysis finds a higher risk of death in the long term...

New data, just published in the Journal of the American Heart Association (JAHA), suggest that there is an increased risk of death at two...

Medtronic releases Resolute Onyx drug-eluting stent in Japan

Medtronic will release the Resolute Onyx coronary stent system in Japan. According to a press release, the device offers superior deliverability to that of...